Insider and congress filings
Tempus AI, Inc. (TEM)
Free on iOS and Android.
About Tempus AI, Inc.
from the company's filings and listing, as of Oct 26, 2026- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Chief executive
- Eric Lefkofsky
- Employees
- 3,800
- Listed since
- Jun 14, 2024
- Market value
- $12.0B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$1.41
- Dividend yield
- -
Company news
4 articles · newest first| Headline | Source | Date |
|---|---|---|
| Tempus AI presents data on AI pre-screening panel for lung cancerThe panel achieved greater than 80% sensitivity across all 12 biomarkers assessed, with sensitivity exceeding 90% for several. | Company release | Oct 19, 2026 |
| Tempus expands multi-year collaboration with Moderna and MerckThe collaboration centers on intismeran autogene, being evaluated with KEYTRUDA in patients with completely resected stage IIB-IV melanoma. | Company release | Oct 7, 2026 |
| Tempus AI has 13 abstracts accepted for ESMO Congress 2026The European Society for Medical Oncology congress takes place October 23 to 27, 2026, in Madrid. | Company release | Oct 1, 2026 |
| Tempus AI receives FDA 510(k) clearance for its ECG-MR AI productThe product analyzes standard 12-lead resting electrocardiograms to detect signs of undiagnosed moderate or severe mitral regurgitation. | Company release | Sep 28, 2026 |
Written by GetSignal with AI from the company's own SEC filings and press releases; each article links to its source. Not investment advice. Company news from every company we cover
Earnings
6 reported quarters · next on Nov 2, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Jul 30, 2026 | -$0.04 | -$0.14 | $382.5M | $379.7M | EPS beatRevenue in line |
| Q1 FY2026reported May 5, 2026 | -$0.13 | -$0.21 | $348.1M | $345.4M | EPS beatRevenue in line |
| Q4 FY2025reported Feb 24, 2026 | -$0.04 | -$0.04 | $367.2M | $362.6M | EPS beatRevenue in line |
| Q3 FY2025reported Nov 4, 2025 | -$0.11 | -$0.17 | $334.2M | $328.7M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 8, 2025 | -$0.22 | -$0.23 | $314.6M | $297.7M | EPS beatRevenue beat |
| Q1 FY2025reported May 6, 2025 | -$0.24 | -$0.26 | $255.7M | $248.1M | EPS beatRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 7, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| Eric LefkofskyChief Executive Officer, Founder and Chairman | $783K | $40.0M | $720K | $41.5M |
| Ryan FukushimaChief Executive Officer, Data | $423K | $10.7M | $526K | $11.6M |
| Andrew PolovinExecutive Vice President, Chief Legal Officer and Secretary | $610K | $5.7M | $275K | $6.6M |
| James RogersChief Financial Officer | $500K | $5.6M | $225K | $6.4M |
| Erik PhelpsExecutive Vice President, Chief Administrative and Legal Officer and Assistant Secretary | $610K | $3.6M | $373K | $4.6M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
Institutional holders
13F positions as of Jun 30, 2026| Holder | Value | Shares | Shares vs prior qtr | % of shares out |
|---|---|---|---|---|
| ARK Investment Management LLCCathie Wood | $580.6M | 10,022,634 | +4.3% | 5.57% |
| BlackRock, Inc. | $480.3M | 8,291,053 | -7.6% | 4.61% |
| Baillie Gifford & Co | $474.5M | 8,190,133 | -5.3% | 4.55% |
| Softbank Group Corp. | $313.1M | 5,405,406 | 0.0% | 3.00% |
| JPMorgan Chase & Co. | $291.2M | 4,989,062 | +1.1% | 2.77% |
| Vanguard Capital Management LLC | $289.0M | 4,988,038 | +1.4% | 2.77% |
| Vanguard Portfolio Management LLC | $284.7M | 4,914,410 | +5.0% | 2.73% |
| Sumitomo Mitsui Trust Group, Inc. | $236.9M | 4,089,029 | -5.5% | 2.27% |
| Amova Asset Management Americas, Inc. | $236.6M | 4,089,029 | -5.5% | 2.27% |
| Goldman Sachs Group Inc | $217.9M | 3,761,666 | +194.4% | 2.09% |
| Morgan Stanley | $211.6M | 3,652,136 | +75.3% | 2.03% |
| Franklin Templeton Inc | $194.2M | 3,352,768 | +29.9% | 1.86% |
A 13F reports long US equity positions and is filed within 45 days of the quarter end, so these are positions as they stood on Jun 30, 2026. For a manager's whole book see the fund directory. What a 13F covers and leaves out is explained in our guide to Form 13F.
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Open-market insider trades
20 filings shown · newest filing first| Insider | Action | Shares | Price | Value | Trade date | Delay (business days) |
|---|---|---|---|---|---|---|
| Thomas Edward SchoenherrCEO, Diagnostics | Sold · scheduled | 10,281 | $85.00 | $874K | Sep 25, 2026filed Sep 29, 2026 | 2d |
| Eric P. LefkofskyCEO and Chairman | Sold · scheduled · 16 lines | 250,000 | $77.47 | $19.4M | Sep 22, 2026filed Sep 24, 2026 | 2d |
| Ryan FukushimaCEO, Data | Sold · scheduled | 700 | $70.00 | $49K | Sep 16, 2026filed Sep 18, 2026 | 2d |
| Andrew PolovinEVP, Chief Legal Officer | Sold · scheduled | 2,951 | $75.00 | $221K | Sep 17, 2026filed Sep 18, 2026 | 1d |
| Ryan M. BartolucciChief Accounting Officer | Sold · scheduled | 7,062 | $75.00 | $530K | Sep 17, 2026filed Sep 18, 2026 | 1d |
| Eric P. LefkofskyCEO and Chairman | Sold · scheduled · 6 lines | 200,000 | $80.57 | $16.1M | Sep 17, 2026filed Sep 18, 2026 | 1d |
| David R. EpsteinDirector | Sold · scheduled | 250 | $65.55 | $16K | Sep 1, 2026filed Sep 3, 2026 | 2d |
| Jennifer A. DoudnaDirector | Sold · scheduled | 676 | $65.55 | $44K | Sep 1, 2026filed Sep 3, 2026 | 2d |
| Ryan FukushimaCEO, Data | Sold · scheduled · 4 lines | 30,846 | $62.71 | $1.9M | Sep 1, 2026filed Sep 3, 2026 | 2d |
| Nadja WestDirector | Sold · scheduled | 3,000 | $69.00 | $207K | Aug 28, 2026filed Sep 1, 2026 | 2d |
| Eric P. LefkofskyCEO and Chairman | Sold · scheduled · 30 lines | 238,152 | $68.39 | $16.3M | Aug 25, 2026filed Aug 27, 2026 | 2d |
| Eric P. LefkofskyCEO and Chairman | Sold · scheduled · 2 lines | 11,848 | $69.87 | $828K | Aug 25, 2026filed Aug 27, 2026 | 2d |
| Ryan FukushimaCEO, Data | Sold · scheduled | 14,286 | $70.00 | $1.0M | Aug 21, 2026filed Aug 25, 2026 | 2d |
| Thomas Edward SchoenherrCEO, Diagnostics | Sold · scheduled | 2,694 | $70.00 | $189K | Aug 21, 2026filed Aug 25, 2026 | 2d |
| Ryan M. BartolucciChief Accounting Officer | Sold | 6,175 | $49.61 | $306K | Aug 18, 2026filed Aug 20, 2026 | 2d |
| Andrew PolovinEVP, Chief Legal Officer | Sold · scheduled | 7,927 | $56.00 | $444K | Aug 19, 2026filed Aug 20, 2026 | 1d |
| Andrew PolovinEVP, Chief Legal Officer | Sold · scheduled | 22,148 | $49.61 | $1.1M | Aug 18, 2026filed Aug 20, 2026 | 2d |
| James William RogersChief Financial Officer | Sold · scheduled | 26,313 | $60.00 | $1.6M | Aug 19, 2026filed Aug 20, 2026 | 1d |
| James William RogersChief Financial Officer | Sold · scheduled | 22,529 | $49.61 | $1.1M | Aug 18, 2026filed Aug 20, 2026 | 2d |
| Thomas Edward SchoenherrCEO, Diagnostics | Sold · scheduled · 6 lines | 8,082 | $58.40 | $472K | Aug 19, 2026filed Aug 20, 2026 | 1d |
One row is one filing, newest filing first. A filing that reported its trade in several tranches is summed, priced at the weighted average, and marked with its line count. Scheduled: set up in advance under a Rule 10b5-1 trading plan. The delay counts business days from the trade to the filing, the unit of Form 4's two business day deadline: weekends and federal holidays are skipped. How the filing itself works is explained in our guide to Form 4.
Congress trades in TEM
1 disclosure of 1 on record · median 7d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Nancy PelosiSpouse | Stock | Purchase | $50,001 - $100,000 | -3.9%S&P 500 +9.8% · -13.7 pts vs S&P 500 | Jan 16, 2026 | Jan 23, 2026 | 7d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in TEM, filterable by party, chamber, type and account.
Members of Congress reporting a position
2 members · estimate, as of Oct 20, 20262 members report a position (estimated). The largest estimated position is in the $50,001 - $100,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Nancy Pelosi | Democrat · House | $50,001 - $100,000 | 0.1% |
| Robert Bresnahan | Republican · House | $1,001 - $15,000 | 0.1% |
Estimate, as of Oct 20, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Are insiders buying or selling TEM?
Across the 20 most recent open-market filings shown here, 0 were purchases and 20 were sales. 19 were scheduled in advance under a Rule 10b5-1 plan.
Which members of Congress have traded TEM?
Nancy Pelosi disclosed TEM transactions in the filings shown here.
Which members of Congress hold TEM?
2 members of Congress report a position in TEM in the estimate we hold as of Oct 20, 2026. The estimated positions belong to Nancy Pelosi and Robert Bresnahan. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are TEM trades disclosed?
Insider filings on this page reached the public a median of 2 business days after the transaction (weekends and federal holidays skipped), against the two business days Form 4 allows. Congressional disclosures took a median of 7 days, against the 45 the STOCK Act allows.
How to read a Form 4
A DECISION THE INSIDER MADE
COMPENSATION PLUMBING
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.